arrivobio.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
Meta Tags
Title ARRIVO
Description The strength of a trusted ARRIVO has a portfolio of diverse late-stage drug candidates through partnering with investors, innovators, and pharmaceutical
Keywords N/A
Server Information
WebSite arrivobio faviconarrivobio.com
Host IP 52.15.237.185
Location United States
Related Websites
Site Rank
More to Explore
arrivobio.com Valuation
US$3,289,087
Last updated: 2023-05-13 06:58:02

arrivobio.com has Semrush global rank of 3,218,007. arrivobio.com has an estimated worth of US$ 3,289,087, based on its estimated Ads revenue. arrivobio.com receives approximately 379,510 unique visitors each day. Its web server is located in United States, with IP address 52.15.237.185. According to SiteAdvisor, arrivobio.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$3,289,087
Daily Ads Revenue US$3,037
Monthly Ads Revenue US$91,083
Yearly Ads Revenue US$1,092,989
Daily Unique Visitors 25,301
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
arrivobio.com. A 7200 IP: 52.15.237.185
arrivobio.com. NS 7200 NS Record: ns37.worldnic.com.
arrivobio.com. NS 7200 NS Record: ns38.worldnic.com.
arrivobio.com. MX 3600 MX Record: 0 arrivobio-com.mail.protection.outlook.com.
arrivobio.com. TXT 3600 TXT Record: v=spf1 include:spf.protection.outlook.com -all
HtmlToTextCheckTime:2023-05-13 06:58:02
Toggle Navigation HOME ABOUT US THERAPEUTIC AREAS Major Depressive Dissorder Pancreatitis Inflammatory Diseases PIPELINE SP-624 for major depressive disorder RABI-767 for severe acute pancreatitis DLX-2323 for inflammatory diseases NEWS CONTACT The strength of a trusted partnership Toggle Navigation HOME ABOUT US THERAPEUTIC AREAS Major Depressive Dissorder Pancreatitis Inflammatory Diseases PIPELINE SP-624 for major depressive disorder RABI-767 for severe acute pancreatitis DLX-2323 for inflammatory diseases NEWS CONTACT The strength of a trusted partnership Home arrivo_admin 2023-03-02T17:50:10+00:00 We are experienced. We are curious. We are problem solvers. At Arrivo, we strive to set a new standard in drug development that starts with the selection of drug candidates and runs throughout clinical development. Our approach and decision-making has delivered a history of excellent returns and product successes that makes us the trusted partner for industry and investors. About Us
HTTP Headers
HTTP/1.1 301 Moved Permanently
Server: nginx/1.20.1
Date: Mon, 20 Dec 2021 22:42:04 GMT
Content-Type: text/html
Content-Length: 169
Connection: keep-alive
Location: https://arrivobio.com/

HTTP/2 200 
server: nginx
date: Mon, 20 Dec 2021 22:42:04 GMT
content-type: text/html; charset=UTF-8
vary: Accept-Encoding
x-pingback: https://arrivobio.com/wp/xmlrpc.php
link: ; rel="https://api.w.org/"
link: ; rel="alternate"; type="application/json"
link: ; rel=shortlink
x-frame-options: SAMEORIGIN
x-xss-protection: 1; mode=block
x-content-type-options: nosniff
arrivobio.com Whois Information
Domain Name: ARRIVOBIO.COM
Registry Domain ID: 1908637609_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.networksolutions.com
Registrar URL: http://networksolutions.com
Updated Date: 2021-01-08T08:54:26Z
Creation Date: 2015-03-09T18:37:09Z
Registry Expiry Date: 2022-03-09T18:37:09Z
Registrar: Network Solutions, LLC
Registrar IANA ID: 2
Registrar Abuse Contact Email: abuse@web.com
Registrar Abuse Contact Phone: +1.8003337680
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS37.WORLDNIC.COM
Name Server: NS38.WORLDNIC.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-12-24T08:14:58Z <<<